MedPath

The role of peri-operative gabapentin in the management of pain following tonsillectomy

Phase 3
Conditions
Pain following tonsillectomy
Post-tonsillectomy analgesic consumption
Post-tonsillectomy nausea
Post-tonsillectomy vomiting
Post-tonsillectomy return to normal activity
Post-tonsillectomy return to normal diet
Surgery - Other surgery
Anaesthesiology - Pain management
Registration Number
ACTRN12613000663752
Lead Sponsor
Department of Surgical Sciences, University of Otago
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Participants will be aged 16 years and over, scheduled for elective tonsillectomy between January 2014 and December 2014

Exclusion Criteria

Exclusion criteria will include contraindications to gabapentin, other concurrent procedures, revision or unilateral tonsillectomy, inability to complete the scoring charts, and those with suspected malignancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure is post-operative pain.[This will be assessed using a VAS, scoring at 2, 4, and 6 hours following surgery and on post-operative days 1 to 14.]
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes will be post-operative analgesic consumption.[This will be assessed on post-operative days 1 to 14 by way of a questionnaire and recovery of un-used analgesia at the end of the 2 week period.];Post-operative nausea[Days 1-14 assessed by validated Postoperative Nausea and Vomiting (PONV) Intensity Scale.];Post-operative vomiting[Days 1-14 assessed by validated Postoperative Nausea and Vomiting (PONV) Intensity Scale.];Post-operative return to normal activity.[Indication by non-validated questionnaire developed specifically for this study of day return to normal activity (From days 1-14).];Post-operative return to normal diet.[Indication by non-validated questionnaire developed specifically for this study of day return to normal diet (From days 1-14).]
© Copyright 2025. All Rights Reserved by MedPath